Navigation Links
WellGen Recognized as Nutraceutical “Innovator” by Global Business Insights
Date:11/18/2009

de natural product solutions to many of the healthcare challenges faced today.”

The report identifies Medical Foods as a potential growth area for the future; commenting that “The medical foods market should be a lucrative place to market products as these products are often reimbursed and high margin.” According to the report, opportunities for medical foods are increasing for a number of reasons:
•   Food technology has advanced to provide for better tasting and better texture medical foods
•   Following its launch, there is an opportunity to expand the consumer base of a medical food based on benefits that are relevant to other populations
•   Advances in science will continue to link additional diseases to diet and nutrition

The report identifies that innovative players like WellGen are transforming nutraceutical development by conducting “pharma-like” research in order to demonstrate the value of their medical food products. Through this approach, WellGen “may be able to publicize more of the research they have undertaken to establish the nature of the effect of the nutraceutical in treating, preventing or curing a disease state”.

The report notes that these innovative start-ups will be attractive acquisition candidates to significant strategic players. “Key Players and Innovative Start-Ups in Nutraceuticals” specifically states, “The technology to support this process of extraction and testing of novel nutraceutical compounds is only now becoming a reality and has driven the growth of a number of companies that are adopting a biotech approach to nutraceutical development. It is likely that this trend will continue and grow, with the smaller innovative companies of today offering acquisition and licensing opportunities for the largest food and ingredients companies in the near future.”
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. WellGen, Inc. Launches Te Ame(TM) Nutritional Supplements With Proven Health Benefits of Proprietary Black Tea Extract
2. Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc.
3. WellGen, Inc. Names Robert M. Hellauer as Chief Financial Officer
4. WellGen, Inc. Names Nancy E. Rawson, Ph.D., Chief Scientific Officer
5. Argonne Recognized for "Green Computing" in 2009 HPCwire Readers' and Editors' Choice Awards
6. Internationally Recognized Bioenergy Experts Convene in Sacramento
7. BioTrends Research Group is Recognized by the Philly 100 for the Second Consecutive Year
8. Two University of Southern California Innovators Recognized by Technology Reviews Prestigious TR35 Listing of the Worlds Top Young Innovators for 2009
9. B. Braun Medical Inc. Recognized by Industry for Manufacturing Influential Medical Devices
10. Techne Corporation Board Member Recognized
11. Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
WellGen Recognized as Nutraceutical “Innovator” by Global Business Insights  
(Date:9/2/2014)... Iowa (PRWEB) September 02, 2014 Press ... of ways to take advantage of the people and ... the schedule below are available throughout the day. Additionally, ... requests with POET and DSM representatives as well as ... interview requests is appreciated. , Please remember to ...
(Date:9/2/2014)...  TransCelerate BioPharma Inc. ("TransCelerate") today announced that ... personal data in Clinical Study Reports (CSRs) that ... document describes an approach to apply when redacting ... related clinical trial documents, and is available ... TransCelerate CSR Redaction approach is to provide organizations ...
(Date:9/2/2014)... Quincy, MA (PRWEB) September 02, 2014 ... announced today the signage of a distribution agreement ... Azelis is now distributing Myriant’s bio-succinic acid in ... Kingdom and Ireland, targeting customers in the industrial ... chemical distribution powerhouse, Azelis offers a far-reaching chemical ...
(Date:9/2/2014)... SAN DIEGO , Sept. 2, 2014 ... announced that the U.S. Patent and Trademark Office (PTO) ... investigational medication being evaluated for weight loss. NB32 is ... bupropion SR. U.S. Patent No. 8,815,889 claims ... naltrexone and bupropion. The patent expires in 2024. If ...
Breaking Biology Technology:Press agenda for Project LIBERTY Grand Opening 2Press agenda for Project LIBERTY Grand Opening 3Press agenda for Project LIBERTY Grand Opening 4Press agenda for Project LIBERTY Grand Opening 5TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 2TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 3Myriant and Azelis Sign European Distribution Agreement for Bio-Succinic Acid 2Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 2Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 3Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 4
... today announced positive results from its Phase IIa ... severely injured trauma patients with hemorrhagic shock causing ... given in addition to standard of care, was ... During hemorrhagic shock, inadequate perfusion of critical organs ...
... 31 Naurex Inc., a clinical stage company developing ... reported that its clinical stage candidate for the treatment ... been selected for inclusion on Windhover,s list of the ... were chosen by a committee that included Windhover Information, ...
... SEATTLE, Aug. 31 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ... of Julie M. Eastland as Chief Financial Officer ... 2010. Ms. Eastland,s responsibilities will include financial management, ... Eastland brings more than 25 years of financial ...
Cached Biology Technology:Sangart, Inc. Reports Positive Phase IIa Data for Novel Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients 2Sangart, Inc. Reports Positive Phase IIa Data for Novel Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients 3Naurex's Novel Antidepressant GLYX-13 Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch 2Naurex's Novel Antidepressant GLYX-13 Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch 3Naurex's Novel Antidepressant GLYX-13 Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch 4Naurex's Novel Antidepressant GLYX-13 Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch 5ONCOTHYREON APPOINTS JULIE M. EASTLAND AS CHIEF FINANCIAL OFFICER 2
(Date:9/2/2014)... limestone is well known as a result of ... (for example, Archaeopteryx). Now, for the first time, ... equivalent of these outcrops - discoveries which include ... treader. , Despite the abundance of fossils in ... obtained from the Late Kimmeridgian equivalents of these ...
(Date:9/1/2014)... has improved steadily in recent yearsspurred in large part ... poor and disparities continue to widen among socioeconomic and ... School of Public Health (HSPH). , "The study provides ... efforts by many groups and individuals to improve U.S. ... indicates that these efforts need to be expanded," said ...
(Date:9/1/2014)... EDT) It may be possible to train the ... foods, according to new research by scientists at the ... (USDA HNRCA) at Tufts University and at Massachusetts General ... & Diabetes , a brain scan study in adult ... reverse the addictive power of unhealthy food while also ...
Breaking Biology News(10 mins):Exceptionally well preserved insect fossils from the Rhône Valley 2Quality of US diet shows modest improvement, but overall remains poor 2Quality of US diet shows modest improvement, but overall remains poor 3Training your brain to prefer healthy foods 2
... inbreeding is a threat against the viabi lity of ... in the new journal PLoS ONE now demonstrates that ... expected. The results show that it is the most ... breeding population. An important consequence of this action of ...
... has discovered that some stealthy mammals have been doing something ... water. , The results of the research by Vanderbilt's Kenneth ... the science journal Nature. He became curious when he observed ... bubbles while swimming. , "This came as a ...
... which can become less effective over time, might retain ... second drug, according to new research in mice conducted ... of the National Institutes of Health, and their partners. ... of Cancer Cell*. , Tamoxifen has been used successfully ...
Cached Biology News:Wolves are suffering less from inbreeding than expected 2Contrary to common wisdom, scientist discovers some mammals can smell objects under water 2Contrary to common wisdom, scientist discovers some mammals can smell objects under water 3Restoring tamoxifen sensitivity in resistant breast cancer cells 2
AC input: 50-60 Hz230 V...
... kits for arraying proteins of interest ... lab equipment. DiscoverLight Protein Array Kits ... protein, cell lysate or antibody in ... include specially designed nitrocellulose membranes with ...
... of DNA or Protein microarrays printed on ... slides. The proprietary design of the cassette ... as is often the case with glass ... analytical cavity volume) eliminates the need for ...
MAb to Myoglobin Cardiac...
Biology Products: